These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31450229)

  • 21. Increased Cardiovascular Risk in Hypertriglyceridemic Patients With Statin-Controlled LDL Cholesterol.
    Nichols GA; Philip S; Reynolds K; Granowitz CB; Fazio S
    J Clin Endocrinol Metab; 2018 Aug; 103(8):3019-3027. PubMed ID: 29850861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy.
    Chung YR; Park SW; Choi SY; Kim SW; Moon KY; Kim JH; Lee K
    Cardiovasc Diabetol; 2017 Jan; 16(1):4. PubMed ID: 28061854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of cardiovascular events in patients with hypertriglyceridaemia: A review of real-world evidence.
    Toth PP; Fazio S; Wong ND; Hull M; Nichols GA
    Diabetes Obes Metab; 2020 Mar; 22(3):279-289. PubMed ID: 31742844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Hypertriglyceridemia with All-Cause Mortality and Atherosclerotic Cardiovascular Events in a Low-Risk Italian Population: The TG-REAL Retrospective Cohort Analysis.
    Arca M; Veronesi C; D'Erasmo L; Borghi C; Colivicchi F; De Ferrari GM; Desideri G; Pontremoli R; Temporelli PL; Perrone V; Degli Esposti L;
    J Am Heart Assoc; 2020 Oct; 9(19):e015801. PubMed ID: 32954906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia.
    Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
    Am J Cardiol; 2016 May; 117(9):1444-8. PubMed ID: 26969416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.
    Vallejo-Vaz AJ; Fayyad R; Boekholdt SM; Hovingh GK; Kastelein JJ; Melamed S; Barter P; Waters DD; Ray KK
    Circulation; 2018 Aug; 138(8):770-781. PubMed ID: 29618599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH Study.
    Ambrosy AP; Yang J; Sung SH; Allen AR; Fitzpatrick JK; Rana JS; Wagner J; Philip S; Abrahamson D; Granowitz C; Go AS
    J Am Heart Assoc; 2021 Oct; 10(20):e020377. PubMed ID: 34622663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: Insights from the START study.
    De Luca L; Temporelli PL; Gulizia MM; Gonzini L; Ammaturo TA; Tedesco L; Pede S; Oliva F; Gabrielli D; Colivicchi F; Averna MR;
    Nutr Metab Cardiovasc Dis; 2023 Dec; 33(12):2398-2405. PubMed ID: 37788956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triglyceride Levels and Fracture Risk in Midlife Women: Study of Women's Health Across the Nation (SWAN).
    Chang PY; Gold EB; Cauley JA; Johnson WO; Karvonen-Gutierrez C; Jackson EA; Ruppert KM; Lee JS
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3297-305. PubMed ID: 27294327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes.
    Elam MB; Ginsberg HN; Lovato LC; Corson M; Largay J; Leiter LA; Lopez C; O'Connor PJ; Sweeney ME; Weiss D; Friedewald WT; Buse JB; Gerstein HC; Probstfield J; Grimm R; Ismail-Beigi F; Goff DC; Fleg JL; Rosenberg Y; Byington RP;
    JAMA Cardiol; 2017 Apr; 2(4):370-380. PubMed ID: 28030716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind, double-dummy, randomized, placebo-controlled trial to evaluate the effect of statin therapy on triglyceride levels in Mexican hypertriglyceridemic patients.
    Talavera JO; Martinez G; Cervantes JL; Marin JA; Rodriguez-Briones I; Gonzalez JG; Ocampo R; Sanchez-Mijangos H; Bernal-Rosales LP; Polanco A
    Curr Med Res Opin; 2013 Apr; 29(4):379-86. PubMed ID: 23323877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia.
    Maki KC; Guyton JR; Orringer CE; Hamilton-Craig I; Alexander DD; Davidson MH
    J Clin Lipidol; 2016; 10(4):905-914. PubMed ID: 27578122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl.
    Posadas-Sánchez R; Posadas-Romero C; Mendoza-Pérez E; Caracas-Portilla NA; Cardoso-Saldaña G; Medina-Urrutia A; Jorge-Galarza E; Juárez-Rojas JG
    Am J Cardiol; 2012 Mar; 109(5):636-41. PubMed ID: 22169129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertriglyceridemia: the importance of identifying patients at risk.
    Kushner PA; Cobble ME
    Postgrad Med; 2016 Nov; 128(8):848-858. PubMed ID: 27710158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Medical Care Utilization and Costs Among Patients With Statin-Controlled Low-Density Lipoprotein Cholesterol With Versus Without Hypertriglyceridemia.
    Nichols GA; Philip S; Reynolds K; Granowitz CB; O'Keeffe-Rosetti M; Fazio S
    Am J Cardiol; 2018 Oct; 122(7):1128-1132. PubMed ID: 30086877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia.
    Christian JB; Arondekar B; Buysman EK; Johnson SL; Seeger JD; Jacobson TA
    J Clin Lipidol; 2012; 6(5):450-61. PubMed ID: 23009781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study).
    Ballantyne CM; Braeckman RA; Bays HE; Kastelein JJ; Otvos JD; Stirtan WG; Doyle RT; Soni PN; Juliano RA
    J Clin Lipidol; 2015; 9(3):377-83. PubMed ID: 26073397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.